Oiling the Brain: a Review of Randomized Controlled Trials of Omega-3 Fatty Acids in Psychopathology Across the Lifespan

Overview

Journal Nutrients

Date 2012 Jan 19

PMID 22254013

Citations 42

Authors

Natalie Sinn

Catherine Milte

Peter R C Howe

Affiliations

Soon will be listed here.

Abstract

Around one in four people suffer from mental illness at some stage in their lifetime. There is increasing awareness of the importance of nutrition, particularly omega-3 polyunsaturated fatty acids (n-3 PUFA), for optimal brain development and function. Hence in recent decades, researchers have explored effects of n-3 PUFA on mental health problems over the lifespan, from developmental disorders in childhood, to depression, aggression, and schizophrenia in adulthood, and cognitive decline, dementia and Alzheimer's disease in late adulthood. This review provides an updated overview of the published and the registered clinical trials that investigate effects of n-3 PUFA supplementation on mental health and behavior, highlighting methodological differences and issues.

Citing Articles

Can Vıtamın D Reduce the Need for SSRI by Modulatıng Serotonın Synthesıs?: A Revıew of Recent Lıterature.

Bostan Z, Sare Bulut M, Gezmen Karadag M Curr Nutr Rep. 2025; 14(1):39.

PMID: 40025236 PMC: 11872774. DOI: 10.1007/s13668-025-00630-7.

The Association of Intake of Omega-3-Fatty Acid Sources with Psychological Distress and Binge Eating Disorder Among Female College Students in Saudi Arabia.

Mosli R, Alsulami H, Alghamdi R, Kutbi H Nutr Metab Insights. 2024; 17:11786388241308183.

PMID: 39712487 PMC: 11660061. DOI: 10.1177/11786388241308183.

Cognitive Decline in Ageing and Disease: Risk factors, Genetics and Treatments.

Colita E, Mateescu V, Olaru D, Popa-Wagner A Curr Health Sci J. 2024; 50(2):170-180.

PMID: 39371061 PMC: 11447500. DOI: 10.12865/CHSJ.50.02.02.

Nutraceuticals in Psychiatric Disorders: A Systematic Review.

Bozzatello P, Novelli R, Montemagni C, Rocca P, Bellino S Int J Mol Sci. 2024; 25(9).

PMID: 38732043 PMC: 11084672. DOI: 10.3390/ijms25094824.

Effects of a Mediterranean Diet Intervention on Maternal Stress, Well-Being, and Sleep Quality throughout Gestation-The IMPACT-BCN Trial.

Casas I, Nakaki A, Pascal R, Castro-Barquero S, Youssef L, Genero M Nutrients. 2023; 15(10).

PMID: 37242244 PMC: 10223296. DOI: 10.3390/nu15102362.

References

Crowley T, Mikulich S, MacDonald M, Young S, Zerbe G . Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug Alcohol Depend. 1998; 49(3):225-37. DOI: 10.1016/s0376-8716(98)00016-7. View

Keck Jr P, Mintz J, McElroy S, Freeman M, Suppes T, Frye M . Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006; 60(9):1020-2. DOI: 10.1016/j.biopsych.2006.03.056. View

Taylor K, Higgins C, Calvin C, Hall J, Easton T, McDaid A . Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukot Essent Fatty Acids. 2000; 63(1-2):75-8. DOI: 10.1054/plef.2000.0195. View

Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues J, Touchon J, Vellas B . Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement. 2009; 5(2):114-21. DOI: 10.1016/j.jalz.2009.01.008. View

Harris W, von Schacky C . The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med. 2004; 39(1):212-20. DOI: 10.1016/j.ypmed.2004.02.030. View

Carney R, Freedland K, Rubin E, Rich M, Steinmeyer B, Harris W . Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009; 302(15):1651-7. PMC: 3477788. DOI: 10.1001/jama.2009.1487. View

Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G . Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids. 2001; 36(9):937-44. DOI: 10.1007/s11745-001-0804-7. View

Moriguchi T, Loewke J, Garrison M, Catalan J, Salem Jr N . Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res. 2001; 42(3):419-27. View

Baker S . A biochemical approach to the problem of dyslexia. J Learn Disabil. 1985; 18(10):581-4. DOI: 10.1177/002221948501801003. View

10.

Edwards R, Peet M, Shay J, Horrobin D . Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998; 48(2-3):149-55. DOI: 10.1016/s0165-0327(97)00166-3. View

11.

Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N . The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest. 1996; 97(4):1129-33. PMC: 507162. DOI: 10.1172/JCI118507. View

12.

Marangell L, Martinez J, Zboyan H, Kertz B, Kim H, Puryear L . A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003; 160(5):996-8. DOI: 10.1176/appi.ajp.160.5.996. View

13.

Dullemeijer C, Durga J, Brouwer I, van de Rest O, Kok F, Brummer R . n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr. 2007; 86(5):1479-85. DOI: 10.1093/ajcn/86.5.1479. View

14.

Gauthier S, Reisberg B, Zaudig M, Petersen R, Ritchie K, Broich K . Mild cognitive impairment. Lancet. 2006; 367(9518):1262-70. DOI: 10.1016/S0140-6736(06)68542-5. View

15.

Mitchell E, Aman M, Turbott S, Manku M . Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila). 1987; 26(8):406-11. DOI: 10.1177/000992288702600805. View

16.

Young G, Conquer J . Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 2005; 45(1):1-28. DOI: 10.1051/rnd:2005001. View

17.

Assisi A, Banzi R, Buonocore C, Capasso F, Di Muzio V, Michelacci F . Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol. 2006; 21(6):319-36. DOI: 10.1097/01.yic.0000224790.98534.11. View

18.

Froehlich J . Opioid peptides. Alcohol Health Res World. 1997; 21(2):132-6. PMC: 6826828. View

19.

Galli C, Trzeciak H, Paoletti R . Effects of essential fatty acid deficiency on myelin and various subcellular structures in rat brain. J Neurochem. 1972; 19(8):1863-7. DOI: 10.1111/j.1471-4159.1972.tb01475.x. View

20.

Fenton W, Hibbeln J, Knable M . Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000; 47(1):8-21. DOI: 10.1016/s0006-3223(99)00092-x. View